As one of the most widely-used prescriptions withdrawn from the market, Rofecobi
As one of the most widely-used prescriptions withdrawn from the market, Rofecobix highlights issues facing public health leaders during a drug recall. With approval by the Food and Drug Administration in 1999, Merck marketed the drug for public use. In 2004, the drug was recalled for safety and cardiovascular problems developed in patients taking the […]
As one of the most widely-used prescriptions withdrawn from the market, Rofecobi Read More »